下一代癌症疗法:将实验进步转化为临床实践
Eftal Kale1, Eren Guzes1, Feyzanur Alatas1
1Faculty of Medicine, TOBB University of Economics and Technology, Söğütözü District, Söğütözü Avenue No. 43, Z-06/02, 06560 Ankara, Turkey.
Postgraduate medical journal
|January 21, 2026
概括
创新的癌症疗法,包括个性化免疫疗法和人工智能驱动的策略,提供了新的希望. 本综述涵盖了先进的治疗方法,以改善患者的治疗结果,并改变癌症护理.
科学领域:
- 在瘤学瘤学.
- 生物技术是生物技术.
- 医疗信息学 医疗信息学
背景情况:
- 癌症治疗正在迅速发展,采用了新的方法.
- 越来越需要治疗方法来改善患者的治疗结果并减少副作用.
研究的目的:
- 提供关于尖端癌症治疗的全面概述.
- 评估下一代癌症治疗的好处,局限性和未来方向.
主要方法:
- 对临床批准和实验性癌症疗法的审查.
- 检查个性化免疫疗法,向分子治疗,基因编辑和人工智能驱动的策略.
主要成果:
- 下一代疗法有望提高疗效和减少副作用.
- 个性化免疫疗法,向分子治疗,基因编辑和人工智能驱动的战略是进步的关键领域.
结论:
- 将先进的癌症疗法整合到临床实践中具有显著的前景.
- 这些创新方法有可能改变癌症护理并改善患者的治疗结果.
相关概念视频
Cancer Therapies
9.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.9K
Targeted Cancer Therapies
8.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.7K
Translation
155.7K
Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
155.7K
Translation
17.6K
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Proteins are...
Translation Produces the Building Blocks of Life
Proteins are...
17.6K
Initiation of Translation
38.4K
Initiating translation is complex because it involves multiple molecules. Initiator tRNA, ribosomal subunits, and eukaryotic initiation factors (eIFs) are all required to assemble on the initiation codon of mRNA. This process consists of several steps that are mediated by different eIFs.
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
38.4K
Gene Therapy
27.4K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.4K


